💉RIKEN: Genome editing prevents Alzheimer’s disease
RIKEN Laboratory for Neurosciences Research Center for Neurosciences Research Team Leader Nishi Makoto Tomonori and research teams such as Kenichi Nagata researchers using genome editing technology to develop amyloid β that causes Alzheimer’s disease [2] We found a genetic deletion that suppresses accumulation of peptide (Aβ) (figure).
The results of this research are expected to be the basis for the identification of new protective mutations [4] in the human population and lead to the development of prophylactic treatment methods such as nucleic acid drugs.
This research will be published in the UK online science magazine “Nature Communications” (May 4, Japan time May 4th).
RIKEN
— Translated by TokioX —